Callie Bryan - Senior Scientist, Discovery Chemistry

Callie Bryan

Senior Scientist, Discovery Chemistry

"It is a humbling honor to do what I love every day: work on challenging and important therapies to help patients."
Years at Genentech

I am currently a Senior Scientist and Project Team Leader for a Research Oncology target. In addition, I work with colleagues across gRED to enable target evaluation, very early stage project investigation and technology that would be beneficial to Discovery Chemistry and the broader organization. Prior to that, I have had the pleasure of contributing to several programs across therapeutic areas, first from the bench and then in a series of leadership roles.

Since starting at Genentech in 2012 as a scientist in the Discovery Chemistry department, I have also remained deeply committed to Environmental Sustainability as is the entire Roche/Genentech organization and have worked on or led several teams and initiatives seeking to apply Green Chemistry within gRED, the Roche organization and the broader Pharma Industry through the ACS GCI Pharma roundtable. Prior to Genentech, I was a Scientist and Senior Scientist at Amgen in the Medicinal Chemistry Department.

Featured Publication

Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances.

J Med Chem. 2018 Oct 25;61(20):9030-9058.

Bryan MC, Rajapaksa NS.